Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2026)

Treace Medical Concepts' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $51.9 million for Q1 2026.

• Quarterly Cash & Current Investments fell 31.85% year-over-year to $51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.9 million (down 31.85% YoY) and the FY2025 annual result came in at $48.4 million, down 36.09% from the prior year.
• Cash & Current Investments was $51.9 million for Q1 2026 at Treace Medical Concepts, up from $48.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $170.7 million in Q1 2023 and bottomed at $48.4 million in Q4 2025.
• A 5-year average of $94.0 million and a median of $88.9 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 507.25% — and 2024, when it plunged 38.57%.
• Treace Medical Concepts' Cash & Current Investments stood at $81.3 million in 2022, then soared by 51.62% to $123.2 million in 2023, then plunged by 38.57% to $75.7 million in 2024, then tumbled by 36.09% to $48.4 million in 2025, then rose by 7.21% to $51.9 million in 2026.
• Business Quant data shows TMCI's Cash & Current Investments at $51.9 million in Q1 2026, $48.4 million in Q4 2025, and $57.4 million in Q3 2025.